Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity
Open Access
- 5 April 2011
- journal article
- clinical trial
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 30
Abstract
To evaluate feasibility and toxicity of carbon ion therapy for treatment of sinonasal malignancies. First site of treatment failure in malignant tumours of the paranasal sinuses and nasal cavity is mostly in-field, local control hence calls for dose escalation which has so far been hampered by accompanying acute and late toxicity. Raster-scanned carbon ion therapy offers the advantage of sharp dose gradients promising increased dose application without increase of side-effects. Twenty-nine patients with various sinonasal malignancies were treated from 11/2009 to 08/2010. Accompanying toxicity was evaluated according to CTCAE v.4.0. Tumor response was assessed according to RECIST. Seventeen patients received treatment as definitive RT, 9 for local relapse, 2 for re-irradiation. All patients had T4 tumours (median CTV1 129.5 cc, CTV2 395.8 cc), mostly originating from the maxillary sinus. Median dose was 73 GyE mostly in mixed beam technique as IMRT plus carbon ion boost. Median follow-up was 5.1 months [range: 2.4-10.1 months]. There were 7 cases with grade 3 toxicity (mucositis, dysphagia) but no other higher grade acute reactions; 6 patients developed grade 2 conjunctivits, no case of early visual impairment. Apart from alterations of taste, all symptoms had resolved at 8 weeks post RT. Overall radiological response rate was 50% (CR and PR). Carbon ion therapy is feasible; despite high doses, acute reactions were not increased and generally resolved within 8 weeks post radiotherapy. Treatment response is encouraging though follow-up is too short to estimate control rates or evaluate potential late effects. Controlled trials are warranted.Keywords
This publication has 43 references indexed in Scilit:
- Proton radiation therapy for primary sphenoid sinus malignancies: Treatment outcome and prognostic factorsHead & Neck, 2009
- Outcome of craniofacial resection in patients 70 years of age and olderHead & Neck, 2006
- Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniquesCancer, 2005
- Complications of craniofacial resection for malignant tumors of the skull base: Report of an International Collaborative StudyHead & Neck, 2005
- Paranasal Sinus Malignancies: An 18‐Year Single Institution ExperienceThe Laryngoscope, 2002
- Malignant tumors of the nasal cavity and paranasal sinusesHead & Neck, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Cancer of the Nasal Cavity and Paranasal Sinuses:A Clinico-pathological Study of 277 PatientsActa Oncologica, 1997
- Fast neutron radiation therapyCritical Reviews in Oncology/Hematology, 1992
- Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinusesClinical Otolaryngology, 1980